Lyell Immunopharma
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LYEL and other ETFs, options, and stocks.About LYEL
Lyell Immunopharma, Inc. operates as a holding company, which engages in the development of cell-based immunotherapies for human diseases. The company was founded by Richard D.
LYEL Key Statistics
Stock Snapshot
With a market cap of 330.62M, Lyell Immunopharma(LYEL) trades at $17.21. The stock has a price-to-earnings ratio of -0.73.
On 2025-11-13, Lyell Immunopharma(LYEL) stock traded between a low of $16.97 and a high of $17.63. Shares are currently priced at $17.21, which is +1.4% above the low and -2.4% below the high.
Lyell Immunopharma(LYEL) shares are trading with a volume of 8.9K, against a daily average of 26.24K.
In the last year, Lyell Immunopharma(LYEL) shares hit a 52-week high of $23.40 and a 52-week low of $7.65.
In the last year, Lyell Immunopharma(LYEL) shares hit a 52-week high of $23.40 and a 52-week low of $7.65.
LYEL News
“Lyell is well positioned with two next-generation CAR T-cell product candidates, each with promising clinical data. We look forward to effectively executing on...